Baseline serum miR-125b levels predict virologic response to nucleos(t)ide analogue treatment in patients with HBeAg-positive chronic hepatitis B

about

Baseline serum miR-125b levels predict virologic response to nucleos(t)ide analogue treatment in patients with HBeAg-positive chronic hepatitis B

Item

http://www.wikidata.org/entity/Q57787108

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Baseline serum miR-125b levels predict virologic response to nucleos

@nl

Baseline serum miR-125b levels ...... g-positive chronic hepatitis B

@en

type

Item

label

Baseline serum miR-125b levels predict virologic response to nucleos

@nl

Baseline serum miR-125b levels ...... g-positive chronic hepatitis B

@en

prefLabel

Baseline serum miR-125b levels predict virologic response to nucleos

@nl

Baseline serum miR-125b levels ...... g-positive chronic hepatitis B

@en

P1476

Baseline serum miR-125b levels ...... g-positive chronic hepatitis B

@en

P2093

Fahong Li

http://www.w3.org/2001/XMLSchema#string

Jiming Zhang

http://www.w3.org/2001/XMLSchema#string

Jingwen Gu

http://www.w3.org/2001/XMLSchema#string

Jinyu Wang

http://www.w3.org/2001/XMLSchema#string

Minhui Dong

http://www.w3.org/2001/XMLSchema#string

Pu Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Analyzing real-time PCR data by the comparative C(T) method

microRNA functions

Early hepatitis B viral DNA clearance predicts treatment response at week 96

AASLD guidelines for treatment of chronic hepatitis B.

Efficacy of telbivudine in Taiwanese chronic hepatitis B patients compared with GLOBE extension study and predicting treatment outcome by HBV DNA kinetics at week 24.

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.

2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.

Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy.

A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication.

The expression of miR-125b-5p is increased in the serum of patients with chronic hepatitis B infection and inhibits the detection of hepatitis B virus surface antigen.

P304

3805-3812

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2018.6685

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30344656

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6176193

http://www.w3.org/2001/XMLSchema#string